Alerts will be sent to your verified email
Verify EmailSOLARA
Solara Active Pharma
|
IOL Chem & Pharma
|
Morepen Laboratories
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Manufacturing Capacity - Ibuprofen
|
5000.0 MTPA | 12000.0 MTPA | n/a |
US DMF Filings
|
230.0 . | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
-10.41 % | 8.9 % | 13.43 % |
5yr average Equity Multiplier
|
1.99 | 1.42 | 1.68 |
5yr Average Asset Turnover Ratio
|
0.54 | 0.99 | 1.29 |
5yr Avg Net Profit Margin
|
-7.28 % | 6.28 % | 5.93 % |
Price to Book
|
2.98 | 2.09 | 2.57 |
P/E
|
132.81 | 33.53 | 32.04 |
5yr Avg Cash Conversion Cycle
|
28.67 Days | 37.81 Days | 12.78 Days |
Inventory Days
|
111.94 Days | 65.55 Days | 54.64 Days |
Days Receivable
|
95.97 Days | 86.45 Days | 65.45 Days |
Days Payable
|
146.85 Days | 100.1 Days | 96.29 Days |
5yr Average Interest Coverage Ratio
|
0.25 | 15.8 | 39.11 |
5yr Avg ROCE
|
2.1 % | 12.63 % | 15.77 % |
5yr Avg Operating Profit Margin
|
9.63 % | 10.64 % | 8.68 % |
5 yr average Debt to Equity
|
0.7 | 0.04 | 0.04 |
5yr CAGR Net Profit
|
-69.98 % | -9.63 % | 3.98 % |
5yr Average Return on Assets
|
-3.67 % | 6.27 % | 7.67 % |
Shareholdings
|
|||
Promoter Holding
|
42.01 % | 52.62 % | 35.65 % |
Share Pledged by Promoters
|
38.95 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
1.61 % | 8.93 % | -1.09 % |
Change in Mutual Fund Holding (3 Yrs)
|
-1.56 % | 0.0 | 0.0 |
Solara Active Pharma
|
IOL Chem & Pharma
|
Morepen Laboratories
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|